Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | metabotropic GABA-B receptor subtype 2 | 0.0011 | 0.0119 | 0.0119 |
Chlamydia trachomatis | pyruvate kinase | 0.0035 | 0.0825 | 0.5 |
Trypanosoma brucei | calpain, putative | 0.0119 | 0.3346 | 1 |
Plasmodium falciparum | pyruvate kinase | 0.0035 | 0.0825 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0049 | 0.1247 | 0.9242 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0035 | 0.0852 | 0.6319 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0324 | 0.2402 |
Echinococcus granulosus | pyruvate kinase | 0.0035 | 0.0825 | 0.612 |
Schistosoma mansoni | pyruvate kinase | 0.0035 | 0.0825 | 0.6621 |
Plasmodium vivax | pyruvate kinase, putative | 0.0035 | 0.0825 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0119 | 0.3346 | 1 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0825 | 0.0825 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0052 | 0.1349 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0029 | 0.0658 | 0.5281 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.1247 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.0119 | 0.3346 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0007 | 0.0012 | 0.0012 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0042 | 0.1057 | 0.1057 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0049 | 0.1247 | 0.9242 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0324 | 0.2402 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0035 | 0.0825 | 0.0825 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0324 | 0.2402 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0035 | 0.0825 | 0.612 |
Loa Loa (eye worm) | glutamate receptor | 0.0017 | 0.0292 | 0.0292 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0035 | 0.0825 | 1 |
Loa Loa (eye worm) | tumor suppressor | 0.0343 | 1 | 1 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0024 | 0.0514 | 0.5 |
Echinococcus multilocularis | pyruvate kinase | 0.0035 | 0.0825 | 0.612 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0021 | 0.041 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0659 | 0.0659 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0038 | 0.0939 | 0.0939 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0119 | 0.3346 | 1 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0035 | 0.0825 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.0119 | 0.3346 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0021 | 0.041 | 0.3291 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0049 | 0.1247 | 0.1247 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0324 | 0.2402 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0035 | 0.0852 | 0.6837 |
Loa Loa (eye worm) | pyruvate kinase | 0.0035 | 0.0825 | 0.0825 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0024 | 0.0514 | 0.0514 |
Trypanosoma brucei | variant surface glycoprotein (VSG), putative | 0.0119 | 0.3346 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0514 | 0.0514 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0035 | 0.0825 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0029 | 0.0658 | 0.5281 |
Mycobacterium ulcerans | pyruvate kinase | 0.0035 | 0.0825 | 0.5 |
Loa Loa (eye worm) | receptor family ligand binding region containing protein | 0.0011 | 0.0119 | 0.0119 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0035 | 0.0825 | 0.5 |
Brugia malayi | Temporarily assigned gene name protein 44 | 0.0029 | 0.0659 | 0.0659 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0052 | 0.1349 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.1247 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.1247 | 1 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0035 | 0.0825 | 1 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0035 | 0.0825 | 0.5 |
Brugia malayi | Receptor family ligand binding region containing protein | 0.0011 | 0.0119 | 0.0119 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0119 | 0.3346 | 1 |
Brugia malayi | pyruvate kinase | 0.0007 | 0.0012 | 0.0012 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0119 | 0.0119 |
Schistosoma mansoni | pyruvate kinase | 0.0035 | 0.0825 | 0.6621 |
Brugia malayi | pyruvate kinase, muscle isozyme | 0.0007 | 0.0012 | 0.0012 |
Loa Loa (eye worm) | pyruvate kinase | 0.0035 | 0.0825 | 0.0825 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0035 | 0.0825 | 0.5 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0048 | 0.123 | 0.9868 |
Echinococcus granulosus | pyruvate kinase | 0.0018 | 0.0324 | 0.2402 |
Echinococcus multilocularis | pyruvate kinase | 0.0035 | 0.0825 | 0.612 |
Echinococcus multilocularis | protein quaking | 0.0029 | 0.0658 | 0.4881 |
Echinococcus granulosus | hypothetical protein | 0.0029 | 0.0658 | 0.4881 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0049 | 0.1247 | 0.9242 |
Loa Loa (eye worm) | pyruvate kinase | 0.0035 | 0.0825 | 0.0825 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0659 | 0.0659 |
Echinococcus multilocularis | pyruvate kinase | 0.0027 | 0.0608 | 0.451 |
Giardia lamblia | Pyruvate kinase | 0.0035 | 0.0825 | 1 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0035 | 0.0852 | 0.6319 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0049 | 0.1247 | 0.9242 |
Trypanosoma brucei | hypothetical protein | 0.0119 | 0.3346 | 1 |
Echinococcus granulosus | protein quaking | 0.0029 | 0.0658 | 0.4881 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0035 | 0.0825 | 1 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Loa Loa (eye worm) | glutamate receptor | 0.0042 | 0.1057 | 0.1057 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1349 | 0.1349 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0035 | 0.0825 | 0.0825 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0049 | 0.1247 | 0.1247 |
Schistosoma mansoni | pyruvate kinase | 0.0018 | 0.0324 | 0.2599 |
Brugia malayi | Pyruvate kinase, alpha/beta domain containing protein | 0.001 | 0.0107 | 0.0107 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0119 | 0.3346 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0119 | 0.3346 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0018 | 0.0324 | 0.2402 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.